Direct involvement of BRCA1 in the development of breast and ovarian cancer is suggested by the finding that the BRCA1 promoter region CpG island is methylated in a proportion of breast and ovarian cancers.	"BRCA1	22	27	Gene_or_gene_product"	"breast	50	56	Cancer"	"ovarian cancer	61	75	Cancer"	"BRCA1	113	118	Gene_or_gene_product"	"breast	179	185	Cancer"	"ovarian cancers	190	205	Cancer"	"[{""token"": ""BRCA1"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""ovarian cancers"", ""start_span"": 190, ""end_span"": 205, ""type"": ""Cancer""}]"
Activation of MybER both prevented the growth arrest induced by interleukin - 6 ( IL - 6) and rapidly restored c - myc expression in nearly terminal differentiated cells that had been exposed to IL - 6 for 3 days.	"MybER	14	19	Gene_or_gene_product"	"interleukin - 6	64	79	Gene_or_gene_product"	"IL - 6	82	88	Gene_or_gene_product"	"c - myc	111	118	Gene_or_gene_product"	"cells	164	169	Cell"	"IL - 6	195	201	Gene_or_gene_product"	"[{""token"": ""MybER"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 6"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Cell""}, {""token"": ""IL - 6"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}]"
In this work, we show that an 11 - amino acid peptide derived from the second immunoglobulin - like domain of Flt - 1 functions as an angiogenic inhibitor in chick chorioallantoic membrane and inhibited VEGF - induced vascular permeability in Miles ' assay without binding to VEGF directly.	"Flt - 1	110	117	Gene_or_gene_product"	"chick	158	163	Organism"	"chorioallantoic membrane	164	188	Multi"	"VEGF	203	207	Gene_or_gene_product"	"vascular	218	226	Multi"	"VEGF	276	280	Gene_or_gene_product"	"[{""token"": ""Flt - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 218, ""end_span"": 226, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 276, ""end_span"": 280, ""type"": ""Gene_or_gene_product""}]"
The authors detected both nm23 - H1 and nm23 - H2 mRNA levels in 47 tissues samples of patients with carcinoma of buccal mucosa ( CBM) by quantitative reverse transcription PCR amplification.	"nm23 - H1	26	35	Gene_or_gene_product"	"nm23 - H2	40	49	Gene_or_gene_product"	"tissues samples	68	83	Tissue"	"patients	87	95	Organism"	"carcinoma of buccal mucosa	101	127	Cancer"	"CBM	130	133	Cancer"	"[{""token"": ""nm23 - H1"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues samples"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""carcinoma of buccal mucosa"", ""start_span"": 101, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""CBM"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Cancer""}]"
Both PLD1 - and PLD2 - mediated cell cycle distributions in stable cell lines revealed an increased fraction of cells in the S phase compared with control cells.	"PLD1	5	9	Gene_or_gene_product"	"PLD2	16	20	Gene_or_gene_product"	"cell	32	36	Cell"	"cell lines	67	77	Cell"	"cells	112	117	Cell"	"cells	155	160	Cell"	"[{""token"": ""PLD1"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Cell""}]"
Interestingly, the level of cyclin D3 protein, known as an activator of G ( 1) to S phase transition in the cell cycle, was aberrantly high in cells overexpressing PLD1 and PLD2 compared with control cells.	"cyclin D3	28	37	Gene_or_gene_product"	"cell	108	112	Cell"	"cells	143	148	Cell"	"PLD1	164	168	Gene_or_gene_product"	"PLD2	173	177	Gene_or_gene_product"	"cells	200	205	Cell"	"[{""token"": ""cyclin D3"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""PLD1"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Cell""}]"
Interestingly, FRTL - 5 - RhoA QL cells express less Tg and TTF - 1 than wild - type FRTL - 5 ( FRTL - 5 - vector) or FRTL - 5 - RhoA N19, suggesting a loss at the differentiation stage.	"RhoA	26	30	Gene_or_gene_product"	"Tg	53	55	Gene_or_gene_product"	"TTF - 1	60	67	Gene_or_gene_product"	"FRTL - 5	85	93	Cell"	"FRTL - 5	96	104	Cell"	"RhoA	129	133	Gene_or_gene_product"	"[{""token"": ""RhoA"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""FRTL - 5"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""RhoA"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"
In this report we studied the effects of SFLLR, an agonist of the activated thrombin receptor and thrombin receptor peptide and non peptide antagonists on angiogenesis in the chick chorioallantoic membrane ( CAM) system.	"SFLLR	41	46	Gene_or_gene_product"	"thrombin receptor	76	93	Gene_or_gene_product"	"thrombin receptor	98	115	Gene_or_gene_product"	"chick	175	180	Organism"	"chorioallantoic membrane	181	205	Multi"	"CAM	208	211	Multi"	"[{""token"": ""SFLLR"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 181, ""end_span"": 205, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Multi""}]"
Thrombin and SFLLR activated progelatinase A ( MMP - 2) in the culture medium of human umbilical cord endothelial cells ( HUVECs).	"Thrombin	0	8	Gene_or_gene_product"	"SFLLR	13	18	Gene_or_gene_product"	"progelatinase A	29	44	Gene_or_gene_product"	"MMP - 2	47	54	Gene_or_gene_product"	"human umbilical cord endothelial cells	81	119	Cell"	"HUVECs	122	128	Cell"	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""SFLLR"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""progelatinase A"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""human umbilical cord endothelial cells"", ""start_span"": 81, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Cell""}]"
In contrast, there was no association between the expression of AP - 2alpha or AP - 2beta and the level of ErbB - 3, or between AP - 2alpha and AP - 2gamma double positivity and ErbB - 3 expression.	"AP - 2alpha	64	75	Gene_or_gene_product"	"AP - 2beta	79	89	Gene_or_gene_product"	"ErbB - 3	107	115	Gene_or_gene_product"	"AP - 2alpha	128	139	Gene_or_gene_product"	"AP - 2gamma	144	155	Gene_or_gene_product"	"ErbB - 3	178	186	Gene_or_gene_product"	"[{""token"": ""AP - 2alpha"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2beta"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2alpha"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2gamma"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
Moreover, expression of a dominant negative AP - 2 protein, AP - 2delta ( deleted residues 31 - 117), not only repressed the ErbB - 3 promoter activity but also suppressed endogenous ErbB - 3 transcription in the ErbB - 3 overexpressing cell line MRC - 5VA.	"AP - 2	44	50	Gene_or_gene_product"	"AP - 2delta	60	71	Gene_or_gene_product"	"ErbB - 3	125	133	Gene_or_gene_product"	"ErbB - 3	183	191	Gene_or_gene_product"	"ErbB - 3	213	221	Gene_or_gene_product"	"cell line MRC - 5VA	237	256	Cell"	"[{""token"": ""AP - 2"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2delta"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell line MRC - 5VA"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Cell""}]"
An intracellular complex containing NRP1 and KDR was immunoprecipitated from EC by anti - NRP1 antibodies only in the presence of VEGF165.	"intracellular	3	16	Immaterial_anatomical_entity"	"NRP1	36	40	Gene_or_gene_product"	"KDR	45	48	Gene_or_gene_product"	"EC	77	79	Cell"	"anti - NRP1 antibodies	83	105	Gene_or_gene_product"	"VEGF165	130	137	Gene_or_gene_product"	"[{""token"": ""intracellular"", ""start_span"": 3, ""end_span"": 16, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""NRP1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""anti - NRP1 antibodies"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
These complexes are formed on the surface of EC and in a juxtacrine manner via association of tumor cell NRP1 and EC KDR.	"surface	34	41	Cellular_component"	"EC	45	47	Cell"	"tumor cell	94	104	Cell"	"NRP1	105	109	Gene_or_gene_product"	"EC	114	116	Cell"	"KDR	117	120	Gene_or_gene_product"	"[{""token"": ""surface"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Cellular_component""}, {""token"": ""EC"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""NRP1"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 114, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""KDR"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"
Most of the tumor - suppressive properties of Pten are dependent on its lipid phosphatase activity, which inhibits the phosphatidylinositol - 3 ' - kinase ( PI3K) / Akt signaling pathway through dephosphorylation of phosphatidylinositol - ( 3, 4, 5) - triphosphate.	"tumor	12	17	Cancer"	"Pten	46	50	Gene_or_gene_product"	"lipid	72	77	Chemical"	"phosphatidylinositol - 3 ' - kinase	119	154	Gene_or_gene_product"	"PI3K	157	161	Gene_or_gene_product"	"Akt	165	168	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""Pten"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipid"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""phosphatidylinositol - 3 ' - kinase"", ""start_span"": 119, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"
We identify here hADA3, human homologue of the yeast transcriptional coactivator yADA3, as a novel E6 - interacting protein and a target of E6 - induced degradation.	"hADA3	17	22	Gene_or_gene_product"	"human	24	29	Organism"	"yeast	47	52	Organism"	"yADA3	81	86	Gene_or_gene_product"	"E6	99	101	Gene_or_gene_product"	"E6	140	142	Gene_or_gene_product"	"[{""token"": ""hADA3"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""yeast"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""yADA3"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
Thyroid transcription factor - 1 ( TTF - 1) is expressed in lung adenocarcinomas and thyroid carcinomas but not in adenocarcinomas arising from other sites.	"Thyroid transcription factor - 1	0	32	Gene_or_gene_product"	"TTF - 1	35	42	Gene_or_gene_product"	"lung adenocarcinomas	60	80	Cancer"	"thyroid carcinomas	85	103	Cancer"	"adenocarcinomas	115	130	Cancer"	"sites	150	155	Multi"	"[{""token"": ""Thyroid transcription factor - 1"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinomas"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""thyroid carcinomas"", ""start_span"": 85, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""adenocarcinomas"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""sites"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Multi""}]"
For patients with adenocarcinomas in the lung, TTF - 1 staining is now routinely used to distinguish a primary lung cancer from a lung metastasis.	"patients	4	12	Organism"	"adenocarcinomas	18	33	Cancer"	"lung	41	45	Organ"	"TTF - 1	47	54	Gene_or_gene_product"	"lung cancer	111	122	Cancer"	"lung	130	134	Organ"	"[{""token"": ""patients"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Organism""}, {""token"": ""adenocarcinomas"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Organ""}, {""token"": ""TTF - 1"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organ""}]"
When the metastatic lung carcinomas were subtyped, TTF - 1 staining was noted in 11 of 11 ( 100%) adenocarcinomas, in 6 of 7 ( 86%) small - cell carcinomas, in 15 of 19 ( 79%) large - cell carcinomas, and in none of 3 ( 0%) squamous cell carcinomas.	"lung carcinomas	20	35	Cancer"	"TTF - 1	51	58	Gene_or_gene_product"	"adenocarcinomas	98	113	Cancer"	"small - cell carcinomas	132	155	Cancer"	"large - cell carcinomas	176	199	Cancer"	"squamous cell carcinomas	224	248	Cancer"	"[{""token"": ""lung carcinomas"", ""start_span"": 20, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""TTF - 1"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenocarcinomas"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""small - cell carcinomas"", ""start_span"": 132, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""large - cell carcinomas"", ""start_span"": 176, ""end_span"": 199, ""type"": ""Cancer""}, {""token"": ""squamous cell carcinomas"", ""start_span"": 224, ""end_span"": 248, ""type"": ""Cancer""}]"
TTF - 1 staining is very reliable in discerning whether a brain metastasis has arisen from a pulmonary or nonpulmonary site, particularly when dealing with adenocarcinomas and large - cell carcinomas.	"TTF - 1	0	7	Gene_or_gene_product"	"brain	58	63	Organ"	"pulmonary	93	102	Multi"	"nonpulmonary site	106	123	Multi"	"adenocarcinomas	156	171	Cancer"	"large - cell carcinomas	176	199	Cancer"	"[{""token"": ""TTF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""pulmonary"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Multi""}, {""token"": ""nonpulmonary site"", ""start_span"": 106, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""adenocarcinomas"", ""start_span"": 156, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""large - cell carcinomas"", ""start_span"": 176, ""end_span"": 199, ""type"": ""Cancer""}]"
In contrast, caspase - 3, Fas ligand, Fas / CD95, and PAI showed an inverse correlation to lymph node involvement.	"caspase - 3	13	24	Gene_or_gene_product"	"Fas ligand	26	36	Gene_or_gene_product"	"Fas	38	41	Gene_or_gene_product"	"CD95	44	48	Gene_or_gene_product"	"PAI	54	57	Gene_or_gene_product"	"lymph node	91	101	Multi"	"[{""token"": ""caspase - 3"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Multi""}]"
In cell culture, the compound 317615 2HCl, a potent inhibitor of VEGF - stimulated HUVEC proliferation, was not very effective against MX - 1 breast cancer cells ( IC50 = 8. 1 microM) or SKOV - 3 ovarian carcinoma cells ( IC50 = 9. 5 microM).	"cell	3	7	Cell"	"317615 2HCl	30	41	Chemical"	"VEGF	65	69	Gene_or_gene_product"	"HUVEC	83	88	Cell"	"MX - 1 breast cancer cells	135	161	Cell"	"SKOV - 3 ovarian carcinoma cells	187	219	Cell"	"[{""token"": ""cell"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""317615 2HCl"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""MX - 1 breast cancer cells"", ""start_span"": 135, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""SKOV - 3 ovarian carcinoma cells"", ""start_span"": 187, ""end_span"": 219, ""type"": ""Cell""}]"
Treatment of wild - type ( wt) p53 ALL cells ( EU - 3 cell line) with doxorubicin caused accumulation of p53, resulting in dramatic down - regulation of survivin, depletion of cells in G ( 2) / M, and apoptosis ( increased sub - G ( 1) compartment).	"p53	31	34	Gene_or_gene_product"	"EU - 3 cell line	47	63	Cell"	"doxorubicin	70	81	Chemical"	"p53	105	108	Gene_or_gene_product"	"survivin	153	161	Gene_or_gene_product"	"cells	176	181	Cell"	"[{""token"": ""p53"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""EU - 3 cell line"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""p53"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cell""}]"
FGF2 - stimulated microvessel formation was inhibited by sequestration of FGF2 via addition of soluble FGF receptor ( FGFR) chimera protein or anti - FGF2 antibodies.	"FGF2	0	4	Gene_or_gene_product"	"microvessel	18	29	Tissue"	"FGF2	74	78	Gene_or_gene_product"	"FGF receptor	103	115	Gene_or_gene_product"	"FGFR	118	122	Gene_or_gene_product"	"FGF2	150	154	Gene_or_gene_product"	"[{""token"": ""FGF2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvessel"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Tissue""}, {""token"": ""FGF2"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF receptor"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFR"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF2"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
Furthermore, slow release administration by subcutaneous injection using an Alzet osmotic pump of a potent and bio - stable T140 analog, 4F - benzoyl - TN14003, gave a partial, but statistically significant ( P < / = 0. 05 ( t - test)) reduction in pulmonary metastasis of MDA - MB - 231 in SCID mice, even though no attempt was made to inhibit other important targets such as CCR7.	"T140 analog	124	135	Chemical"	"4F - benzoyl - TN14003	137	159	Chemical"	"pulmonary	249	258	Organ"	"MDA - MB - 231	273	287	Cell"	"SCID mice	291	300	Organism"	"CCR7	377	381	Gene_or_gene_product"	"[{""token"": ""T140 analog"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""4F - benzoyl - TN14003"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Chemical""}, {""token"": ""pulmonary"", ""start_span"": 249, ""end_span"": 258, ""type"": ""Organ""}, {""token"": ""MDA - MB - 231"", ""start_span"": 273, ""end_span"": 287, ""type"": ""Cell""}, {""token"": ""SCID mice"", ""start_span"": 291, ""end_span"": 300, ""type"": ""Organism""}, {""token"": ""CCR7"", ""start_span"": 377, ""end_span"": 381, ""type"": ""Gene_or_gene_product""}]"
Hypoxia - inducible factor 1 ( HIF - 1) activates vascular endothelial growth factor ( VEGF) gene expression in hypoxic / ischemic tissue.	"Hypoxia - inducible factor 1	0	28	Gene_or_gene_product"	"HIF - 1	31	38	Gene_or_gene_product"	"vascular endothelial growth factor	50	84	Gene_or_gene_product"	"VEGF	87	91	Gene_or_gene_product"	"hypoxic	112	119	Tissue"	"ischemic tissue	122	137	Tissue"	"[{""token"": ""Hypoxia - inducible factor 1"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 50, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxic"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Tissue""}, {""token"": ""ischemic tissue"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Tissue""}]"
In epithelial cells, EphA2 and E - cadherin co - localize to sites of cell - cell contact, and it has been shown that E - cadherin regulates EphA2.	"epithelial cells	3	19	Cell"	"EphA2	21	26	Gene_or_gene_product"	"E - cadherin	31	43	Gene_or_gene_product"	"cell - cell contact	70	89	Cellular_component"	"E - cadherin	118	130	Gene_or_gene_product"	"EphA2	141	146	Gene_or_gene_product"	"[{""token"": ""epithelial cells"", ""start_span"": 3, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""EphA2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell - cell contact"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""E - cadherin"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"
This study aimed to clarify the relationship between the expression of the EphA2 and E - cadherin proteins and clinicopathological characteristics, with reference to the expression levels of both EphA2 and E - cadherin, in patients with colorectal cancer.	"EphA2	75	80	Gene_or_gene_product"	"E - cadherin	85	97	Gene_or_gene_product"	"EphA2	196	201	Gene_or_gene_product"	"E - cadherin	206	218	Gene_or_gene_product"	"patients	223	231	Organism"	"colorectal cancer	237	254	Cancer"	"[{""token"": ""EphA2"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 237, ""end_span"": 254, ""type"": ""Cancer""}]"
We performed immunohistochemical staining of EphA2 and E - cadherin with EphA2 and E - cadherin monoclonal antibodies in samples from 194 primary lesions of colorectal cancer.	"EphA2	45	50	Gene_or_gene_product"	"E - cadherin	55	67	Gene_or_gene_product"	"EphA2	73	78	Gene_or_gene_product"	"E - cadherin	83	95	Gene_or_gene_product"	"primary lesions	138	153	Cancer"	"colorectal cancer	157	174	Cancer"	"[{""token"": ""EphA2"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary lesions"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Cancer""}]"
Its Hsp90 inhibition results in multiple anti - tumor - specific effects, such as degradation of Hsp90 - client proteins involved in cell growth, survival, and specific transformation, inhibition of cancer cell growth, delay of cell cycle progression, induction of morphological and functional changes, and apoptosis.	"Hsp90	4	9	Gene_or_gene_product"	"tumor	48	53	Cancer"	"Hsp90	97	102	Gene_or_gene_product"	"cell	133	137	Cell"	"cancer cell	199	210	Cell"	"cell	228	232	Cell"	"[{""token"": ""Hsp90"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""Hsp90"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""cancer cell"", ""start_span"": 199, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Cell""}]"
It is normally produced in bone, teeth, kidney and epithelial lining tissues and is found in plasma and breast milk.	"bone	27	31	Tissue"	"teeth	33	38	Organ"	"kidney	40	46	Organ"	"epithelial lining tissues	51	76	Tissue"	"plasma	93	99	Organism_substance"	"breast milk	104	115	Organism_substance"	"[{""token"": ""bone"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organ""}, {""token"": ""kidney"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Organ""}, {""token"": ""epithelial lining tissues"", ""start_span"": 51, ""end_span"": 76, ""type"": ""Tissue""}, {""token"": ""plasma"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""breast milk"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Organism_substance""}]"
Glucocorticoid receptor - induced MAPK phosphatase - 1 ( MPK - 1) expression inhibits paclitaxel - associated MAPK activation and contributes to breast cancer cell survival.	"Glucocorticoid receptor	0	23	Gene_or_gene_product"	"MAPK phosphatase - 1	34	54	Gene_or_gene_product"	"MPK - 1	57	64	Gene_or_gene_product"	"paclitaxel	86	96	Chemical"	"MAPK	110	114	Gene_or_gene_product"	"breast cancer cell	145	163	Cell"	"[{""token"": ""Glucocorticoid receptor"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK phosphatase - 1"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""MPK - 1"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""paclitaxel"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cell"", ""start_span"": 145, ""end_span"": 163, ""type"": ""Cell""}]"
Furthermore, induction of MKP - 1 correlated with the inhibition of extracellular signal - regulated kinase ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) activity, whereas p38 activity was minimally affected.	"MKP - 1	26	33	Gene_or_gene_product"	"extracellular signal - regulated kinase	68	107	Gene_or_gene_product"	"ERK1 / 2	110	118	Gene_or_gene_product"	"c - Jun N - terminal kinase	124	151	Gene_or_gene_product"	"JNK	154	157	Gene_or_gene_product"	"p38	177	180	Gene_or_gene_product"	"[{""token"": ""MKP - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 68, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 124, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
These findings demonstrate a requirement for VEGFR1 + haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1 + VLA - 4 + clusters dictate organ - specific tumour spread.	"VEGFR1	45	51	Gene_or_gene_product"	"fibronectin	154	165	Gene_or_gene_product"	"VEGFR1	170	176	Gene_or_gene_product"	"VLA - 4	179	186	Gene_or_gene_product"	"organ	206	211	Organ"	"tumour	223	229	Cancer"	"[{""token"": ""VEGFR1"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""organ"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Organ""}, {""token"": ""tumour"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Cancer""}]"
To this end, we generated endothelial cell lines stably expressing vGPCR or key KSHV latently expressed proteins ( vCyclin, vFlip, and LANA1).	"endothelial cell lines	26	48	Cell"	"vGPCR	67	72	Gene_or_gene_product"	"KSHV	80	84	Organism"	"vCyclin	115	122	Gene_or_gene_product"	"vFlip	124	129	Gene_or_gene_product"	"LANA1	135	140	Gene_or_gene_product"	"[{""token"": ""endothelial cell lines"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""KSHV"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""vCyclin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""vFlip"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""LANA1"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"
The endothelial cell line expressing vGPCR was rendered sensitive to treatment with the nucleoside analogue ganciclovir by using a bicistronic construct coexpressing the herpes simplex virus 1 thymidine kinase.	"endothelial cell line	4	25	Cell"	"vGPCR	37	42	Gene_or_gene_product"	"nucleoside	88	98	Chemical"	"ganciclovir	108	119	Chemical"	"herpes simplex virus 1	170	192	Organism"	"thymidine kinase	193	209	Gene_or_gene_product"	"[{""token"": ""endothelial cell line"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleoside"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""ganciclovir"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""herpes simplex virus 1"", ""start_span"": 170, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""thymidine kinase"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
S. c. injection into nude mice with mixed - cell populations formed tumors that approximate the ratio of vGPCR - expressing and KSHV latent gene - expressing cells.	"nude mice	21	30	Organism"	"mixed - cell populations	36	60	Cell"	"tumors	68	74	Cancer"	"vGPCR	105	110	Gene_or_gene_product"	"KSHV	128	132	Organism"	"cells	158	163	Cell"	"[{""token"": ""nude mice"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""mixed - cell populations"", ""start_span"": 36, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""vGPCR"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""KSHV"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cell""}]"
Surprisingly, despite the expression of KSHV latent genes in the vast majority of tumor cells, specifically targeting only the few vGPCR - expressing cells in established tumors resulted in tumor regression.	"KSHV	40	44	Organism"	"tumor cells	82	93	Cell"	"vGPCR	131	136	Gene_or_gene_product"	"cells	150	155	Cell"	"tumors	171	177	Cancer"	"tumor	190	195	Cancer"	"[{""token"": ""KSHV"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""tumor cells"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Cancer""}]"
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus - positive hepatocellular carcinomas.	"Hepatitis B virus	0	17	Organism"	"human	39	44	Organism"	"chromosome 17p	45	59	Cellular_component"	"p53	69	72	Gene_or_gene_product"	"chromosome	107	117	Cellular_component"	"virus - positive hepatocellular carcinomas	138	180	Cancer"	"[{""token"": ""Hepatitis B virus"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""chromosome 17p"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""virus - positive hepatocellular carcinomas"", ""start_span"": 138, ""end_span"": 180, ""type"": ""Cancer""}]"
Hepatitis B virus ( HBV) is strongly associated with the development of HCC in people chronically infected with the virus, but the mechanism of viral involvement remains unclear.	"Hepatitis B virus	0	17	Organism"	"HBV	20	23	Organism"	"HCC	72	75	Cancer"	"people	79	85	Organism"	"virus	116	121	Organism"	"viral	144	149	Organism"	"[{""token"": ""Hepatitis B virus"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""HBV"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""HCC"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""people"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""virus"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""viral"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism""}]"
The transmembrane peptidase prostate - specific membrane antigen ( PSMA) is universally upregulated in the vasculature of solid tumors, but its functional role in tumor angiogenesis has not been investigated.	"transmembrane	4	17	Cellular_component"	"prostate - specific membrane antigen	28	64	Gene_or_gene_product"	"PSMA	67	71	Gene_or_gene_product"	"vasculature	107	118	Multi"	"solid tumors	122	134	Cancer"	"tumor	163	168	Cancer"	"[{""token"": ""transmembrane"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Cellular_component""}, {""token"": ""prostate - specific membrane antigen"", ""start_span"": 28, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""solid tumors"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cancer""}]"
PLGA - heparin microspheres released out bFGF in a more sustained manner with a smaller extent of initial burst than PLGA microspheres, indicating that surface immobilized heparin controlled the release rate of bFGF.	"PLGA	0	4	Chemical"	"heparin	7	14	Chemical"	"bFGF	41	45	Gene_or_gene_product"	"PLGA	117	121	Chemical"	"heparin	172	179	Chemical"	"bFGF	211	215	Gene_or_gene_product"	"[{""token"": ""PLGA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"
bFGF loaded PLGA - HP microspheres showed sustained release profiles of bFGF in vitro, demonstrating reversible and specific binding of bFGF to immobilized heparin.	"bFGF	0	4	Gene_or_gene_product"	"PLGA	12	16	Chemical"	"HP	19	21	Chemical"	"bFGF	72	76	Gene_or_gene_product"	"bFGF	136	140	Gene_or_gene_product"	"heparin	156	163	Chemical"	"[{""token"": ""bFGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""HP"", ""start_span"": 19, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""heparin"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical""}]"
Lysophosphatidic acid ( LPA) levels are elevated in ascites from ovarian cancer patients, but its potential role in ovarian cancer metastasis has just begun to be revealed.	"Lysophosphatidic acid	0	21	Chemical"	"LPA	24	27	Chemical"	"ascites	52	59	Organism_substance"	"ovarian cancer	65	79	Cancer"	"patients	80	88	Organism"	"ovarian cancer	116	130	Cancer"	"[{""token"": ""Lysophosphatidic acid"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""LPA"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""ascites"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""ovarian cancer"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Cancer""}]"
"It summarizes strategies to destroy or prevent cancers by targeting their energy production factories, i. e., "" power plants. "" All nucleated animal / human cells have two types of power plants, i. e., systems that make the "" high energy "" compound ATP from ADP and P ( i)."	"cancers	47	54	Cancer"	"animal	142	148	Organism"	"human	151	156	Organism"	"cells	157	162	Cell"	"ATP	249	252	Chemical"	"ADP	258	261	Chemical"	"[{""token"": ""cancers"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""animal"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Chemical""}, {""token"": ""ADP"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Chemical""}]"
"One type is "" glycolysis, "" the other the "" mitochondria. "" In contrast to most normal cells where the mitochondria are the major ATP producers ( > 90%) in fueling growth, human cancers detected via Positron Emission Tomography ( PET) rely on both types of power plants."	"mitochondria	44	56	Cellular_component"	"cells	87	92	Cell"	"mitochondria	103	115	Cellular_component"	"ATP	130	133	Chemical"	"human	172	177	Organism"	"cancers	178	185	Cancer"	"[{""token"": ""mitochondria"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Cellular_component""}, {""token"": ""ATP"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Cancer""}]"
The effect of swainsonine ( active compound of locoweed and a potential anticancer drug) on vascular development showed no differences in sinusoidal diameters at 7 weeks, but a decrease in capillary density was noted.	"swainsonine	14	25	Chemical"	"locoweed	47	55	Organism"	"anticancer	72	82	Cancer"	"vascular	92	100	Multi"	"sinusoidal	138	148	Tissue"	"capillary	189	198	Tissue"	"[{""token"": ""swainsonine"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""locoweed"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""anticancer"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Multi""}, {""token"": ""sinusoidal"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Tissue""}, {""token"": ""capillary"", ""start_span"": 189, ""end_span"": 198, ""type"": ""Tissue""}]"
Together, these results suggest that Tip30 is an intrinsic and negative regulator of MEC proliferation partly through the inhibition of Wisp2 and Igf - 1 expression, and its absence in the mammary gland may predispose MECs to neoplastic transformation.	"Tip30	37	42	Gene_or_gene_product"	"MEC	85	88	Cell"	"Wisp2	136	141	Gene_or_gene_product"	"Igf - 1	146	153	Gene_or_gene_product"	"mammary gland	189	202	Organ"	"MECs	218	222	Cell"	"[{""token"": ""Tip30"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEC"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""Wisp2"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Igf - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary gland"", ""start_span"": 189, ""end_span"": 202, ""type"": ""Organ""}, {""token"": ""MECs"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Cell""}]"
Additionally, the synergistic apoptotic effects of MOG with As2O3 were detected in HL - 60 and primary AML cells, but not in normal cells, suggesting the selective toxicity of their combination to the malignant cells.	"MOG	51	54	Chemical"	"As2O3	60	65	Chemical"	"HL - 60	83	90	Cell"	"primary AML cells	95	112	Cell"	"cells	132	137	Cell"	"malignant cells	201	216	Cell"	"[{""token"": ""MOG"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""As2O3"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""HL - 60"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""primary AML cells"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""malignant cells"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Cell""}]"
Treatment with 25 mg / kg cyclopamine significantly attenuated BrdU incorporation in tumor cells threefold ( P less than 0. 001), in tumor related endothelial cells threefold ( P = 0. 004), and delayed tumor growth by 4 days.	"cyclopamine	26	37	Chemical"	"BrdU	63	67	Chemical"	"tumor cells	85	96	Cell"	"tumor	133	138	Cancer"	"endothelial cells	147	164	Cell"	"tumor	202	207	Cancer"	"[{""token"": ""cyclopamine"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""BrdU"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""endothelial cells"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cancer""}]"
OBJECTIVE: In the present study, we attempted to identify EGFR and TGF - alpha expression and Ki - 67 index in carcinoma ex - pleomorphic adenoma ( Ca ex - PA) and PA.	"EGFR	58	62	Gene_or_gene_product"	"TGF - alpha	67	78	Gene_or_gene_product"	"Ki - 67	94	101	Gene_or_gene_product"	"carcinoma ex - pleomorphic adenoma	111	145	Cancer"	"Ca ex - PA	148	158	Cancer"	"PA	164	166	Pathological_formation"	"[{""token"": ""EGFR"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoma ex - pleomorphic adenoma"", ""start_span"": 111, ""end_span"": 145, ""type"": ""Cancer""}, {""token"": ""Ca ex - PA"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Pathological_formation""}]"
In the immunohistochemical analysis of EGFR and TGF - alpha and Ki67 index, a significant increase was observed in Ca ex - PA, especially with adenocarcinoma, compared with PA and sialadenitis.	"EGFR	39	43	Gene_or_gene_product"	"TGF - alpha	48	59	Gene_or_gene_product"	"Ki67	64	68	Gene_or_gene_product"	"Ca ex - PA	115	125	Cancer"	"adenocarcinoma	143	157	Cancer"	"PA	173	175	Pathological_formation"	"[{""token"": ""EGFR"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki67"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca ex - PA"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Pathological_formation""}]"
The appearance of lipid - bloated subretinal MCs was drusen - like on funduscopy of senescent mice, and CX3CR1 - dependent MC accumulation was associated with an exacerbation of experimental CNV.	"lipid	18	23	Chemical"	"subretinal MCs	34	48	Cell"	"drusen	53	59	Pathological_formation"	"mice	94	98	Organism"	"CX3CR1	104	110	Gene_or_gene_product"	"MC	123	125	Cell"	"[{""token"": ""lipid"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""subretinal MCs"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""drusen"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Pathological_formation""}, {""token"": ""mice"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""CX3CR1"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""MC"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Cell""}]"
Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.	"Smad1	24	29	Gene_or_gene_product"	"Smad5	34	39	Gene_or_gene_product"	"somatic cells	43	56	Cell"	"gonads	76	82	Organ"	"tumor	103	108	Cancer"	"mice	124	128	Organism"	"[{""token"": ""Smad1"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatic cells"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""gonads"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism""}]"
Using tissue - specific ablation in mice, we deleted the BR - SMADs from somatic cells of ovaries and testes.	"tissue	6	12	Tissue"	"mice	36	40	Organism"	"BR - SMADs	57	67	Gene_or_gene_product"	"somatic cells	73	86	Cell"	"ovaries	90	97	Organ"	"testes	102	108	Organ"	"[{""token"": ""tissue"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""BR - SMADs"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatic cells"", ""start_span"": 73, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""ovaries"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Organ""}, {""token"": ""testes"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Organ""}]"
Female double Smad1 Smad5 and triple Smad1 Smad5 Smad8 conditional knockout mice become infertile and develop metastatic granulosa cell tumors.	"Smad1	14	19	Gene_or_gene_product"	"Smad5	20	25	Gene_or_gene_product"	"Smad1	37	42	Gene_or_gene_product"	"Smad5	43	48	Gene_or_gene_product"	"Smad8	49	54	Gene_or_gene_product"	"granulosa cell tumors	121	142	Cancer"	"[{""token"": ""Smad1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad8"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""granulosa cell tumors"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Cancer""}]"
In this article we have focused on a role of IL - 6 as a prognostic factor in several malignancies such as colorectal cancer, breast cancer, gastric cancer and pancreatic cancer.	"IL - 6	45	51	Gene_or_gene_product"	"malignancies	86	98	Cancer"	"colorectal cancer	107	124	Cancer"	"breast cancer	126	139	Cancer"	"gastric cancer	141	155	Cancer"	"pancreatic cancer	160	177	Cancer"	"[{""token"": ""IL - 6"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""gastric cancer"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""pancreatic cancer"", ""start_span"": 160, ""end_span"": 177, ""type"": ""Cancer""}]"
There was no correlation of survivin with bcl - 2 or bax expression, or with other prognostic parameters ( age, tumor size, histologic type, histologic grade, nodal status, and tumor stage) ( P > 0. 05).	"survivin	28	36	Gene_or_gene_product"	"bcl - 2	42	49	Gene_or_gene_product"	"bax	53	56	Gene_or_gene_product"	"tumor	112	117	Cancer"	"nodal	159	164	Multi"	"tumor	177	182	Cancer"	"[{""token"": ""survivin"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""nodal"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Cancer""}]"
Transfection with TSP - 1 and purified TSP - 1 added to NIH3T3 cells did not alter the protein levels of alpha - SMA and desmin but significantly inhibited matrix metalloprotease - 2 activity.	"TSP - 1	18	25	Gene_or_gene_product"	"TSP - 1	39	46	Gene_or_gene_product"	"NIH3T3 cells	56	68	Cell"	"alpha - SMA	105	116	Gene_or_gene_product"	"desmin	121	127	Gene_or_gene_product"	"matrix metalloprotease - 2	156	182	Gene_or_gene_product"	"[{""token"": ""TSP - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""alpha - SMA"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloprotease - 2"", ""start_span"": 156, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"
Laminin - 332 is critical for squamous cell carcinoma ( SCC) tumorigenesis, but targeting it for cancer therapy has been unachievable due to key role of laminin - 332 in promoting tissue integrity.	"Laminin - 332	0	13	Gene_or_gene_product"	"squamous cell carcinoma	30	53	Cancer"	"SCC	56	59	Cancer"	"cancer	97	103	Cancer"	"laminin - 332	153	166	Gene_or_gene_product"	"tissue	180	186	Tissue"	"[{""token"": ""Laminin - 332"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 30, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""SCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""laminin - 332"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Tissue""}]"
G45 antibody treatment induced SCC tumor apoptosis, decreased SCC tumor proliferation, and markedly impaired human SCC tumorigenesis in vivo without affecting normal tissue adhesion.	"G45	0	3	Gene_or_gene_product"	"SCC tumor	31	40	Cancer"	"SCC tumor	62	71	Cancer"	"human	109	114	Organism"	"SCC	115	118	Cancer"	"normal tissue	159	172	Tissue"	"[{""token"": ""G45"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC tumor"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""SCC tumor"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Cancer""}, {""token"": ""normal tissue"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Tissue""}]"
We measured serum IL - 8 and urine IL - 8 levels in patients with NHL, and we compared the concentrations with those of control individuals.	"serum	12	17	Organism_substance"	"IL - 8	18	24	Gene_or_gene_product"	"urine	29	34	Organism_substance"	"IL - 8	35	41	Gene_or_gene_product"	"patients	52	60	Organism"	"NHL	66	69	Cancer"	"[{""token"": ""serum"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""urine"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""NHL"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Cancer""}]"
There was no correlation between the serum and urine concentrations of IL - 8 and clinical variables, the only exception being the international prognostic index ( IPI), which showed a marginal correlation with urine IL - 8 / Cr levels ( P = 0. 07).	"serum	37	42	Organism_substance"	"urine	47	52	Organism_substance"	"IL - 8	71	77	Gene_or_gene_product"	"urine	211	216	Organism_substance"	"IL - 8	217	223	Gene_or_gene_product"	"Cr	226	228	Chemical"	"[{""token"": ""serum"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism_substance""}, {""token"": ""urine"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""urine"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cr"", ""start_span"": 226, ""end_span"": 228, ""type"": ""Chemical""}]"
This technique showed strong abdominal neovascularization in wild - type mice, but not eNOS knockout mice, locally injected with VEGF, as well as stimulation of angiogenesis in NO donor - injected mice.	"abdominal	29	38	Organism_subdivision"	"mice	73	77	Organism"	"eNOS	87	91	Gene_or_gene_product"	"VEGF	129	133	Gene_or_gene_product"	"NO	177	179	Chemical"	"mice	197	201	Organism"	"[{""token"": ""abdominal"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Organism_subdivision""}, {""token"": ""mice"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""eNOS"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""NO"", ""start_span"": 177, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism""}]"
The p75 receptor of neurotrophins ( p75 ( NTR)), which is scarcely present in healthy endothelial cells ( ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type - 1 diabetic mice.	"p75 receptor of neurotrophins	4	33	Gene_or_gene_product"	"endothelial cells	86	103	Cell"	"ECs	106	109	Cell"	"capillary ECs	142	155	Cell"	"peripheral	175	185	Tissue"	"mice	216	220	Organism"	"[{""token"": ""p75 receptor of neurotrophins"", ""start_span"": 4, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""capillary ECs"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""peripheral"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Organism""}]"
Also, the combination of docetaxel and ATRA might allow a reduction in docetaxel doses and by this way may diminish docetaxel adverse effects while maintaining the therapeutic effect in patients with HRPC.	"docetaxel	25	34	Chemical"	"ATRA	39	43	Chemical"	"docetaxel	71	80	Chemical"	"docetaxel	116	125	Chemical"	"patients	186	194	Organism"	"HRPC	200	204	Cancer"	"[{""token"": ""docetaxel"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""docetaxel"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""docetaxel"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Organism""}, {""token"": ""HRPC"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Cancer""}]"
Furthermore, the Y705F / S727E but not the Y705F / S727A mutant induced anchorage - independent growth of noncancerous prostate epithelial cells ( RWPE - 1).	"Y705F	17	22	Amino_acid"	"S727E	25	30	Amino_acid"	"Y705F	43	48	Amino_acid"	"S727A	51	56	Amino_acid"	"noncancerous prostate epithelial cells	106	144	Cell"	"RWPE - 1	147	155	Cell"	"[{""token"": ""Y705F"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Amino_acid""}, {""token"": ""S727E"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Amino_acid""}, {""token"": ""Y705F"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Amino_acid""}, {""token"": ""S727A"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Amino_acid""}, {""token"": ""noncancerous prostate epithelial cells"", ""start_span"": 106, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""RWPE - 1"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Cell""}]"
Thus, our data show that allergic respiratory inflammation may represent a risk factor for the development of lung metastases and suggest that amelioration of the pulmonary inflammation associated with asthma will have a direct and immediate benefit to the 7% to 8% of breast cancer patients with this lung disease.	"respiratory	34	45	Anatomical_system"	"lung metastases	110	125	Cancer"	"pulmonary	163	172	Organ"	"breast cancer	269	282	Cancer"	"patients	283	291	Organism"	"lung	302	306	Organ"	"[{""token"": ""respiratory"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Anatomical_system""}, {""token"": ""lung metastases"", ""start_span"": 110, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Organ""}, {""token"": ""breast cancer"", ""start_span"": 269, ""end_span"": 282, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 283, ""end_span"": 291, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 302, ""end_span"": 306, ""type"": ""Organ""}]"
This compound inhibits cellular ATP production owing to its action on glycolysis and oxidative phosphorylation; however, the specific metabolic steps and mechanisms of 3 - BrPA action in human hepatocellular carcinomas, particularly its effects on mitochondrial energetics, are poorly understood.	"cellular	23	31	Cell"	"ATP	32	35	Chemical"	"3 - BrPA	168	176	Chemical"	"human	187	192	Organism"	"hepatocellular carcinomas	193	218	Cancer"	"mitochondrial	248	261	Cellular_component"	"[{""token"": ""cellular"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""3 - BrPA"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinomas"", ""start_span"": 193, ""end_span"": 218, ""type"": ""Cancer""}, {""token"": ""mitochondrial"", ""start_span"": 248, ""end_span"": 261, ""type"": ""Cellular_component""}]"
The activity of mitochondrial hexokinase was not inhibited by 150 microM 3 - BrPA, but this concentration caused more than 70% inhibition of GAPDH ( glyceraldehyde - 3 - phosphate dehydrogenase) and 3 - phosphoglycerate kinase activities.	"mitochondrial	16	29	Cellular_component"	"hexokinase	30	40	Gene_or_gene_product"	"3 - BrPA	73	81	Chemical"	"GAPDH	141	146	Gene_or_gene_product"	"glyceraldehyde - 3 - phosphate dehydrogenase	149	193	Gene_or_gene_product"	"3 - phosphoglycerate kinase	199	226	Gene_or_gene_product"	"[{""token"": ""mitochondrial"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""hexokinase"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 - BrPA"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""GAPDH"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""glyceraldehyde - 3 - phosphate dehydrogenase"", ""start_span"": 149, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 - phosphoglycerate kinase"", ""start_span"": 199, ""end_span"": 226, ""type"": ""Gene_or_gene_product""}]"
In this study, we have investigated gene knockdown analysis of endothelial Robos, in particular roundabout 4 ( robo4), the predominant Robo in endothelial cells using small interfering RNA technology in vitro.	"endothelial	63	74	Cell"	"Robos	75	80	Gene_or_gene_product"	"roundabout 4	96	108	Gene_or_gene_product"	"robo4	111	116	Gene_or_gene_product"	"Robo	135	139	Gene_or_gene_product"	"endothelial cells	143	160	Cell"	"[{""token"": ""endothelial"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""Robos"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""roundabout 4"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""robo4"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 143, ""end_span"": 160, ""type"": ""Cell""}]"
Robo1 and Robo4 interact and share molecules such as Slit2, Mena and Vilse, a Cdc42 - GAP.	"Robo1	0	5	Gene_or_gene_product"	"Robo4	10	15	Gene_or_gene_product"	"Slit2	53	58	Gene_or_gene_product"	"Mena	60	64	Gene_or_gene_product"	"Vilse	69	74	Gene_or_gene_product"	"Cdc42 - GAP	78	89	Gene_or_gene_product"	"[{""token"": ""Robo1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""Slit2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mena"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Vilse"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42 - GAP"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
Antioxidant N - acetyl - l - aspartate ( NAC) decreased vessels number in tumors formed by cells with inactivated p53 and inhibited their growth.	"N - acetyl - l - aspartate	12	38	Chemical"	"NAC	41	44	Chemical"	"vessels	56	63	Multi"	"tumors	74	80	Cancer"	"cells	91	96	Cell"	"p53	114	117	Gene_or_gene_product"	"[{""token"": ""N - acetyl - l - aspartate"", ""start_span"": 12, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""NAC"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""vessels"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"
An anti - IL - 8 Ab inhibited endothelial cell proliferation induced by cancer cell produced IL - 8 and tumors with low IL - 8 levels exhibited decreased angiogenesis.	"anti - IL - 8 Ab	3	19	Chemical"	"endothelial cell	30	46	Cell"	"cancer cell	72	83	Cell"	"IL - 8	93	99	Gene_or_gene_product"	"tumors	104	110	Cancer"	"IL - 8	120	126	Gene_or_gene_product"	"[{""token"": ""anti - IL - 8 Ab"", ""start_span"": 3, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 30, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""cancer cell"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""IL - 8"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""IL - 8"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
Our results strongly suggest that estradiol has a critical role in the regulation of IL - 8 in normal human breast tissue and human breast cancer.	"estradiol	34	43	Chemical"	"IL - 8	85	91	Gene_or_gene_product"	"human	102	107	Organism"	"breast tissue	108	121	Tissue"	"human	126	131	Organism"	"breast cancer	132	145	Cancer"	"[{""token"": ""estradiol"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""breast tissue"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Cancer""}]"
However, MKN - 28, MKN - 45, MKN - 74, and SNU16 cells did not express membrane CXCR4.	"MKN - 28	9	17	Cell"	"MKN - 45	19	27	Cell"	"MKN - 74	29	37	Cell"	"SNU16 cells	43	54	Cell"	"membrane	71	79	Cellular_component"	"CXCR4	80	85	Gene_or_gene_product"	"[{""token"": ""MKN - 28"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""MKN - 45"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""MKN - 74"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""SNU16 cells"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cellular_component""}, {""token"": ""CXCR4"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}]"
Using a murine incisional wound healing model this study was carried out to investigate the roles of estrogen and progesterone on macrophage activation during the wound healing response.	"murine	8	14	Organism"	"wound	26	31	Pathological_formation"	"estrogen	101	109	Chemical"	"progesterone	114	126	Chemical"	"macrophage	130	140	Cell"	"wound	163	168	Pathological_formation"	"[{""token"": ""murine"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Pathological_formation""}, {""token"": ""estrogen"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""progesterone"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""macrophage"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Pathological_formation""}]"
The effects on endothelial cells occur in vitro at low drug concentrations, which do not affect microtubule gross morphology, do not cause microtubule bundling or microtubule loss and do not induce cell cycle arrest, apoptosis, or cell death.	"endothelial cells	15	32	Cell"	"microtubule	96	107	Cellular_component"	"microtubule	139	150	Cellular_component"	"microtubule	163	174	Cellular_component"	"cell	198	202	Cell"	"cell	231	235	Cell"	"[{""token"": ""endothelial cells"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""microtubule"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Cellular_component""}, {""token"": ""microtubule"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Cellular_component""}, {""token"": ""microtubule"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Cell""}]"
In addition, cisplatin markedly reduced MMP2 activity in both conditioned media and cell lysates, increased p38 MAPK and JNK phosphorylation, but did not affect ERK phosphorylation.	"cisplatin	13	22	Chemical"	"MMP2	40	44	Gene_or_gene_product"	"cell lysates	84	96	Organism_substance"	"p38 MAPK	108	116	Gene_or_gene_product"	"JNK	121	124	Gene_or_gene_product"	"ERK	161	164	Gene_or_gene_product"	"[{""token"": ""cisplatin"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""MMP2"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lysates"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Organism_substance""}, {""token"": ""p38 MAPK"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}]"
However, treatment of cells with SB202190 or SP600125, inhibitors of p38 MAPK and JNK respectively, did not affect HUVEC migration.	"cells	22	27	Cell"	"SB202190	33	41	Chemical"	"SP600125	45	53	Chemical"	"p38 MAPK	69	77	Gene_or_gene_product"	"JNK	82	85	Gene_or_gene_product"	"HUVEC	115	120	Cell"	"[{""token"": ""cells"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""SB202190"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""SP600125"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""p38 MAPK"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cell""}]"
Expanded polytetrafluoroethylene ( ePTFE) vascular grafts were coated with perlecan and tested in an ovine carotid interposition model for a period of 6 weeks and assessed using light and scanning microscopy.	"polytetrafluoroethylene	9	32	Chemical"	"ePTFE	35	40	Chemical"	"vascular grafts	42	57	Multi"	"perlecan	75	83	Gene_or_gene_product"	"ovine	101	106	Organism"	"carotid	107	114	Multi"	"[{""token"": ""polytetrafluoroethylene"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""ePTFE"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""vascular grafts"", ""start_span"": 42, ""end_span"": 57, ""type"": ""Multi""}, {""token"": ""perlecan"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovine"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""carotid"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Multi""}]"
Conditioned medium from progestin - treated breast cancer cells stimulates endothelial cell proliferation in the absence though not in the presence of antibody to TSP - 1, indicating that TSP - 1 secreted by breast cancer cells could be pro - angiogenic.	"progestin	24	33	Chemical"	"breast cancer cells	44	63	Cell"	"endothelial cell	75	91	Cell"	"antibody to TSP - 1	151	170	Gene_or_gene_product"	"TSP - 1	188	195	Gene_or_gene_product"	"breast cancer cells	208	227	Cell"	"[{""token"": ""progestin"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""breast cancer cells"", ""start_span"": 44, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""antibody to TSP - 1"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 208, ""end_span"": 227, ""type"": ""Cell""}]"
To understand the molecular mechanisms underlying compound - induced hemangiosarcomas in mice, and therefore, their human relevance, a systems biology approach was undertaken using transcriptomics and Causal Network Modeling from mice treated with 2 - butoxyethanol ( 2 - BE).	"hemangiosarcomas	69	85	Cancer"	"mice	89	93	Organism"	"human	116	121	Organism"	"mice	230	234	Organism"	"2 - butoxyethanol	248	265	Chemical"	"2 - BE	268	274	Chemical"	"[{""token"": ""hemangiosarcomas"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Organism""}, {""token"": ""2 - butoxyethanol"", ""start_span"": 248, ""end_span"": 265, ""type"": ""Chemical""}, {""token"": ""2 - BE"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Chemical""}]"
CONCLUSION: Our results strongly support a role for PI3K / Akt / mTOR pathway in PET, which ties in with the fact that mTOR inhibitors have reached phase III trials in neuroendocrine tumors.	"PI3K	52	56	Gene_or_gene_product"	"Akt	59	62	Gene_or_gene_product"	"mTOR	65	69	Gene_or_gene_product"	"PET	81	84	Cancer"	"mTOR	119	123	Gene_or_gene_product"	"neuroendocrine tumors	168	189	Cancer"	"[{""token"": ""PI3K"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""PET"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""mTOR"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroendocrine tumors"", ""start_span"": 168, ""end_span"": 189, ""type"": ""Cancer""}]"
Several members were detected in insulinoma cell lines and rat islets and expression levels positively correlated with insulin abundance, particularly for p24delta1 and p24beta1.	"insulinoma cell lines	33	54	Cell"	"rat	59	62	Organism"	"islets	63	69	Multi"	"insulin	119	126	Gene_or_gene_product"	"p24delta1	155	164	Gene_or_gene_product"	"p24beta1	169	177	Gene_or_gene_product"	"[{""token"": ""insulinoma cell lines"", ""start_span"": 33, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""insulin"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""p24delta1"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""p24beta1"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"
RESULTS: SPARC expression was mainly in the stromal cells surrounding the colon cancer, and was significant difference in those tissues with the lymph node metastasis and differentiation degree of tumor.	"SPARC	9	14	Gene_or_gene_product"	"stromal cells	44	57	Cell"	"colon cancer	74	86	Cancer"	"tissues	128	135	Tissue"	"lymph node	145	155	Multi"	"tumor	197	202	Cancer"	"[{""token"": ""SPARC"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal cells"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""colon cancer"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""tissues"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Tissue""}, {""token"": ""lymph node"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Cancer""}]"
We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down - regulating mitochondrial activity both in primary fibroblasts and in STAT3 - dependent tumour cell lines.	"STAT3	40	45	Gene_or_gene_product"	"cell	76	80	Cell"	"mitochondrial	143	156	Cellular_component"	"fibroblasts	182	193	Cell"	"STAT3	201	206	Gene_or_gene_product"	"tumour cell lines	219	236	Cell"	"[{""token"": ""STAT3"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""mitochondrial"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Cellular_component""}, {""token"": ""fibroblasts"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Cell""}, {""token"": ""STAT3"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour cell lines"", ""start_span"": 219, ""end_span"": 236, ""type"": ""Cell""}]"
Mild mutations in BRCA2 ( FANCD1) cause Fanconi anemia ( FA) when homozygous, while severe mutations cause common cancers including breast, ovarian, and prostate cancers when heterozygous.	"BRCA2	18	23	Gene_or_gene_product"	"FANCD1	26	32	Gene_or_gene_product"	"cancers	114	121	Cancer"	"breast	132	138	Cancer"	"ovarian	140	147	Cancer"	"prostate cancers	153	169	Cancer"	"[{""token"": ""BRCA2"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""FANCD1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""breast"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""ovarian"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Cancer""}, {""token"": ""prostate cancers"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Cancer""}]"
Associations of KISS1 methylation and its expression with histopathological variables and poor survival suggest the utility of incorporating KISS1 measurement using paraffin - embedded material for tumor stratification and clinical outcome prognosis of patients with uroepithelial neoplasias.	"KISS1	16	21	Gene_or_gene_product"	"KISS1	141	146	Gene_or_gene_product"	"paraffin	165	173	Chemical"	"tumor	198	203	Cancer"	"patients	253	261	Organism"	"uroepithelial neoplasias	267	291	Cancer"	"[{""token"": ""KISS1"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""KISS1"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""paraffin"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 253, ""end_span"": 261, ""type"": ""Organism""}, {""token"": ""uroepithelial neoplasias"", ""start_span"": 267, ""end_span"": 291, ""type"": ""Cancer""}]"
Finally, sorafenib induced autophagy in Huh7 xenograft tumors in nude mice and coadministration with chloroquine significantly suppressed tumor growth compared with sorafenib alone.	"sorafenib	9	18	Chemical"	"Huh7 xenograft tumors	40	61	Cancer"	"nude mice	65	74	Organism"	"chloroquine	101	112	Chemical"	"tumor	138	143	Cancer"	"sorafenib	165	174	Chemical"	"[{""token"": ""sorafenib"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""Huh7 xenograft tumors"", ""start_span"": 40, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""chloroquine"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""sorafenib"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Chemical""}]"
Desensitization of prostaglandin F2 alpha - stimulated inositol phosphate generation in NIH - 3T3 fibroblasts transformed by overexpression of normal c - Ha - ras - 1, c - Ki - ras - 2 and c - N - ras genes.	"prostaglandin F2 alpha	19	41	Chemical"	"inositol phosphate	55	73	Chemical"	"NIH - 3T3 fibroblasts	88	109	Cell"	"c - Ha - ras - 1	150	166	Gene_or_gene_product"	"c - Ki - ras - 2	168	184	Gene_or_gene_product"	"c - N - ras	189	200	Gene_or_gene_product"	"[{""token"": ""prostaglandin F2 alpha"", ""start_span"": 19, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""inositol phosphate"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""NIH - 3T3 fibroblasts"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""c - Ha - ras - 1"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Ki - ras - 2"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - N - ras"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}]"
The stimulation of inositol phosphate generation in control and ras - gene - transformed NIH - 3T3 cells by prostaglandin F2 alpha ( PGF2 alpha) was investigated.	"inositol phosphate	19	37	Chemical"	"control	52	59	Cell"	"ras	64	67	Gene_or_gene_product"	"NIH - 3T3 cells	89	104	Cell"	"prostaglandin F2 alpha	108	130	Chemical"	"PGF2 alpha	133	143	Chemical"	"[{""token"": ""inositol phosphate"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""control"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH - 3T3 cells"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""prostaglandin F2 alpha"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""PGF2 alpha"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical""}]"
These results suggest that desensitization of certain agonist - induced inositol phospholipid responses in ras - transformed cells is a consequence of increased cell proliferation and associated amplification in C - kinase activity and is an indirect consequence of transformation by ras.	"inositol phospholipid	72	93	Chemical"	"ras	107	110	Gene_or_gene_product"	"cells	125	130	Cell"	"cell	161	165	Cell"	"C - kinase	212	222	Gene_or_gene_product"	"ras	284	287	Gene_or_gene_product"	"[{""token"": ""inositol phospholipid"", ""start_span"": 72, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""ras"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""C - kinase"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene_or_gene_product""}]"
Our results suggest that blood flow limits glucose supply to tumor tissue at much higher flow rates than in normal brain which, in turn, is associated with a decrease in tumor glucose utilization.	"blood	25	30	Organism_substance"	"glucose	43	50	Chemical"	"tumor tissue	61	73	Tissue"	"brain	115	120	Organ"	"tumor	170	175	Cancer"	"glucose	176	183	Chemical"	"[{""token"": ""blood"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""tumor tissue"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Tissue""}, {""token"": ""brain"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Chemical""}]"
Depletion of ARD1 by shRNA suppressed PCa cell proliferation, anchorage - independent growth, and xenograft tumor formation in SCID mice, suggesting that AR - dependent ARD1 expression is biologically germane.	"ARD1	13	17	Gene_or_gene_product"	"PCa cell	38	46	Cell"	"xenograft tumor	98	113	Cancer"	"SCID mice	127	136	Organism"	"AR	154	156	Gene_or_gene_product"	"ARD1	169	173	Gene_or_gene_product"	"[{""token"": ""ARD1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCa cell"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""xenograft tumor"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""SCID mice"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Organism""}, {""token"": ""AR"", ""start_span"": 154, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"
Samples were assayed for glucose, lactate, and insulin concentrations and compared statistically with ten control dogs of similar weight and age undergoing an identical dextrose challenge.	"Samples	0	7	Organism_substance"	"glucose	25	32	Chemical"	"lactate	34	41	Chemical"	"insulin	47	54	Gene_or_gene_product"	"dogs	114	118	Organism"	"dextrose	169	177	Chemical"	"[{""token"": ""Samples"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""insulin"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""dogs"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""dextrose"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Chemical""}]"
We assessed the effects of these mutations on the ability of the v - fos protein to transform chicken embryo fibroblasts and to stimulate cellular proliferation of chicken neuroretinal cells.	"v - fos	65	72	Gene_or_gene_product"	"chicken	94	101	Organism"	"embryo fibroblasts	102	120	Cell"	"cellular	138	146	Cell"	"chicken	164	171	Organism"	"neuroretinal cells	172	190	Cell"	"[{""token"": ""v - fos"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""chicken"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Organism""}, {""token"": ""neuroretinal cells"", ""start_span"": 172, ""end_span"": 190, ""type"": ""Cell""}]"
This effect was observed whether the cells had been treated with all - trans - RA in serum - free medium or in medium supplemented with heat - inactivated or acid - treated fetal bovine serum.	"cells	37	42	Cell"	"all - trans - RA	65	81	Chemical"	"serum	85	90	Organism_substance"	"fetal	173	178	Developing_anatomical_structure"	"bovine	179	185	Organism"	"serum	186	191	Organism_substance"	"[{""token"": ""cells"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""all - trans - RA"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism_substance""}, {""token"": ""fetal"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Developing_anatomical_structure""}, {""token"": ""bovine"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Organism""}, {""token"": ""serum"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Organism_substance""}]"
Adult rat urothelial cells were transformed in vitro following treatment with a single dose of N - methyl - N - nitrosourea ( MNU) or MNU treatment followed by promotion with sodium saccharin.	"rat	6	9	Organism"	"urothelial cells	10	26	Cell"	"N - methyl - N - nitrosourea	95	123	Chemical"	"MNU	126	129	Chemical"	"MNU	134	137	Chemical"	"sodium saccharin	175	191	Chemical"	"[{""token"": ""rat"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""urothelial cells"", ""start_span"": 10, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""N - methyl - N - nitrosourea"", ""start_span"": 95, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""MNU"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Chemical""}, {""token"": ""MNU"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""sodium saccharin"", ""start_span"": 175, ""end_span"": 191, ""type"": ""Chemical""}]"
They defined also the predominant origin of new vessels from venules and capillaries, and enabled the evolution of proliferating vessels into arterioles and venules to be documented.	"vessels	48	55	Multi"	"venules	61	68	Multi"	"capillaries	73	84	Tissue"	"vessels	129	136	Multi"	"arterioles	142	152	Multi"	"venules	157	164	Multi"	"[{""token"": ""vessels"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""venules"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""capillaries"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Tissue""}, {""token"": ""vessels"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""arterioles"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Multi""}, {""token"": ""venules"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Multi""}]"
Previous work has shown that a rabbit anti - VCSA serum lyses specifically, in the presence of complement, 51Cr - labelled RSV - transformed cells from different animal species.	"rabbit	31	37	Organism"	"VCSA	45	49	Gene_or_gene_product"	"serum lyses	50	61	Organism_substance"	"51Cr	107	111	Chemical"	"RSV	123	126	Organism"	"cells	141	146	Cell"	"[{""token"": ""rabbit"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""VCSA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum lyses"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Organism_substance""}, {""token"": ""51Cr"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""RSV"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Cell""}]"
The migration activity of heparin and mast cell conditioned medium was blocked by specific antagonists of heparin ( protamine and heparinase), but not by chondroitinase ABC.	"heparin	26	33	Chemical"	"mast cell	38	47	Cell"	"heparin	106	113	Chemical"	"protamine	116	125	Gene_or_gene_product"	"heparinase	130	140	Gene_or_gene_product"	"chondroitinase ABC	154	172	Gene_or_gene_product"	"[{""token"": ""heparin"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""mast cell"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""heparin"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""protamine"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""heparinase"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""chondroitinase ABC"", ""start_span"": 154, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"
Monitoring peroxide - induced changes in GSH and GSSG gave consistent results; e. g., glucose - depleted L. Se ( +) cells exhibited a first order loss of GSH that was substantially faster than that of glucose - depleted L. Se ( -) cells.	"peroxide	11	19	Chemical"	"GSH	41	44	Chemical"	"GSSG	49	53	Chemical"	"glucose	86	93	Chemical"	"GSH	154	157	Chemical"	"glucose	201	208	Chemical"	"[{""token"": ""peroxide"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""GSSG"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Chemical""}]"
The putative metastasis suppressor genes, NME1 ( nm23 - 1) and NME2 ( nm23 - 2), were examined in a model system we developed to approximate the dissemination of melanoma from a primary skin tumor.	"NME1	42	46	Gene_or_gene_product"	"nm23 - 1	49	57	Gene_or_gene_product"	"NME2	63	67	Gene_or_gene_product"	"nm23 - 2	70	78	Gene_or_gene_product"	"melanoma	162	170	Cancer"	"skin tumor	186	196	Cancer"	"[{""token"": ""NME1"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""NME2"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 2"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""skin tumor"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Cancer""}]"
We utilized two autologous human melanoma cell lines, IV Cl 1 and IV Cl 3, which displayed qualitatively different metastatic phenotypes following subdermal inoculation into nude mice.	"human	27	32	Organism"	"melanoma cell lines	33	52	Cell"	"IV Cl 1	54	61	Cell"	"IV Cl 3	66	73	Cell"	"subdermal	147	156	Organism_subdivision"	"nude mice	174	183	Organism"	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""melanoma cell lines"", ""start_span"": 33, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""IV Cl 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""IV Cl 3"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""subdermal"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Organism_subdivision""}, {""token"": ""nude mice"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Organism""}]"
A similar ser120 - gly mutation in NME1 has been found in human neuroblastoma, suggesting that mutation in this region may be a general phenomenon related to tumor progression.	"ser120	10	16	Amino_acid"	"gly	19	22	Amino_acid"	"NME1	35	39	Gene_or_gene_product"	"human	58	63	Organism"	"neuroblastoma	64	77	Cancer"	"tumor	158	163	Cancer"	"[{""token"": ""ser120"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Amino_acid""}, {""token"": ""gly"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Amino_acid""}, {""token"": ""NME1"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""neuroblastoma"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cancer""}]"
E mu cyclin D1 transgenic mice show only very subtle alterations in the cycling behaviour of B - cell populations in the bone marrow compared with normal mice and do not develop lymphoid tumours.	"E mu	0	4	Gene_or_gene_product"	"cyclin D1	5	14	Gene_or_gene_product"	"B - cell populations	93	113	Cell"	"bone marrow	121	132	Multi"	"mice	154	158	Organism"	"lymphoid tumours	178	194	Cancer"	"[{""token"": ""E mu"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cell populations"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Organism""}, {""token"": ""lymphoid tumours"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Cancer""}]"
None of the transformants differentiated into melanophores or iridophores or other neural crest derivatives as seen in goldfish erythrophoroma cells.	"transformants	12	25	Cell"	"melanophores	46	58	Cell"	"iridophores	62	73	Cell"	"neural crest	83	95	Tissue"	"goldfish	119	127	Organism"	"erythrophoroma cells	128	148	Cell"	"[{""token"": ""transformants"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""melanophores"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""iridophores"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""neural crest"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""goldfish"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""erythrophoroma cells"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Cell""}]"
Rats were immunized with irradiated hepatoma cells transduced by herpes viral amplicon vectors containing the genes for GM - CSF, IL - 2 or LacZ.	"Rats	0	4	Organism"	"hepatoma cells	36	50	Cell"	"herpes viral	65	77	Organism"	"GM - CSF	120	128	Gene_or_gene_product"	"IL - 2	130	136	Gene_or_gene_product"	"LacZ	140	144	Gene_or_gene_product"	"[{""token"": ""Rats"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""hepatoma cells"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""herpes viral"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""GM - CSF"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""LacZ"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Separate rats underwent splenocyte and KC harvest for assessment of lymphocyte - and macrophage - mediated tumor cell kill in vitro.	"rats	9	13	Organism"	"splenocyte	24	34	Cell"	"KC	39	41	Cell"	"lymphocyte	68	78	Cell"	"macrophage	85	95	Cell"	"tumor cell	107	117	Cell"	"[{""token"": ""rats"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""splenocyte"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""KC"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""macrophage"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Cell""}]"
GM - CSF or IL - 2 vaccines or gammaIFN decreased tumor nodules significantly ( GM - CSF 13 + / - 4, IL - 2 14 + / - 6 vs. control 75 + / - 24, P < 0. 001).	"GM - CSF	0	8	Gene_or_gene_product"	"IL - 2	12	18	Gene_or_gene_product"	"gammaIFN	31	39	Gene_or_gene_product"	"tumor nodules	50	63	Cancer"	"GM - CSF	80	88	Gene_or_gene_product"	"IL - 2	101	107	Gene_or_gene_product"	"[{""token"": ""GM - CSF"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gammaIFN"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor nodules"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""GM - CSF"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
Suppression of tumor growth by the 3 ' untranslated region of mel - 18 in 3Y1 cells transformed by the E6 and E7 genes of human papillomavirus type 18.	"tumor	15	20	Cancer"	"mel - 18	62	70	Gene_or_gene_product"	"3Y1 cells	74	83	Cell"	"E6	103	105	Gene_or_gene_product"	"E7	110	112	Gene_or_gene_product"	"human papillomavirus type 18	122	150	Organism"	"[{""token"": ""tumor"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""mel - 18"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""3Y1 cells"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""E6"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""human papillomavirus type 18"", ""start_span"": 122, ""end_span"": 150, ""type"": ""Organism""}]"
STUDY DESIGN: Thirty - three archival cytologic specimens from eight patients with histologically confirmed malignant mesothelioma and 13 from patients with metastatic serous effusions were destained and then immunostained with anticalretinin antiserum.	"cytologic specimens	38	57	Tissue"	"patients	69	77	Organism"	"malignant mesothelioma	108	130	Cancer"	"patients	143	151	Organism"	"serous effusions	168	184	Organism_substance"	"antiserum	243	252	Organism_substance"	"[{""token"": ""cytologic specimens"", ""start_span"": 38, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""malignant mesothelioma"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""serous effusions"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Organism_substance""}, {""token"": ""antiserum"", ""start_span"": 243, ""end_span"": 252, ""type"": ""Organism_substance""}]"
We attempted to correlate the expression of human leukocyte antigen DR ( HLA - DR) and tumor infiltration by S - 100 - protein - positive dendritic cells with clinicopathologic features in 165 patients with gastric cancer.	"human leukocyte antigen DR	44	70	Gene_or_gene_product"	"HLA - DR	73	81	Gene_or_gene_product"	"tumor	87	92	Cancer"	"S - 100	109	116	Gene_or_gene_product"	"patients	193	201	Organism"	"gastric cancer	207	221	Cancer"	"[{""token"": ""human leukocyte antigen DR"", ""start_span"": 44, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""HLA - DR"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""S - 100"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 207, ""end_span"": 221, ""type"": ""Cancer""}]"
The absence of functional von Hippel - Lindau ( VHL) tumor suppressor gene leads to the development of neoplasias characteristic of VHL disease, including renal cell carcinoma ( RCC).	"von Hippel - Lindau	26	45	Gene_or_gene_product"	"VHL	48	51	Gene_or_gene_product"	"tumor	53	58	Cancer"	"VHL	132	135	Gene_or_gene_product"	"renal cell carcinoma	155	175	Cancer"	"RCC	178	181	Cancer"	"[{""token"": ""von Hippel - Lindau"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""VHL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""VHL"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinoma"", ""start_span"": 155, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""RCC"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Cancer""}]"
While the response to most treatments was not affected by the VHL gene status, glucose deprivation was found to be much more cytotoxic for RCC cells lacking VHL gene function than for wtVHL - expressing cells.	"VHL	62	65	Gene_or_gene_product"	"glucose	79	86	Chemical"	"RCC cells	139	148	Cell"	"VHL	157	160	Gene_or_gene_product"	"wtVHL	184	189	Gene_or_gene_product"	"cells	203	208	Cell"	"[{""token"": ""VHL"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""RCC cells"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""wtVHL"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Cell""}]"
Furthermore, ubiquitination of cellular proteins was elevated in VHL - deficient cells, particularly after glucose deprivation, supporting a role for the VHL gene in ubiquitin - mediated proteolysis.	"cellular	31	39	Cell"	"VHL	65	68	Gene_or_gene_product"	"cells	81	86	Cell"	"glucose	107	114	Chemical"	"VHL	154	157	Gene_or_gene_product"	"ubiquitin	166	175	Gene_or_gene_product"	"[{""token"": ""cellular"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""VHL"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""ubiquitin"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"
